Pharmaceutical composition comprising a cdk inhibitor and gemcitabine
CA 2502979 A1 · Owner: Gianella-Borradori, Athos · Inventors: Gianella-Borradori, Athos
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A first aspect of the invention relates to a combination comprising a CDK inhibitor and gemcitabine. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and gemcitabine as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously sequentially or , separately administering a CDK inhibitor and gemcitabine to a subject.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 5, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.